Corporate Tech Investors

Debiopharm Diagnostics

Debiopharm Diagnostics is a corporate VC investing group that partners with companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

Debiopharm Diagnostics SA supports innovative diagnostic companies. Diagnostics are an important part of Debiopharm Group's development strategy. Why? Because diagnostics are the foundation of the future of medicine. Diagnostics brings us: Patient stratification for better health outcomes, quicker development process and improved success rates.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

9/13/2022

Transaction History

Our records indicate that Debiopharm Diagnostics invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Managing Director

Thomas Gibbs

        

Founder

Thierry Mauvernay

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Debiopharm Diagnostics has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

DealerSocket | DeFi Technologies

Share this article

About Our Corporate Tech Investing Database

This corporate tech investment data comes via a partnership with VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary